Xenitra Limited has released a press release.
Quarterly Activities/Appendix 5B Cash Flow Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Xenitra
- Aumake and Sinomach Hainan Partner for Hay Exports to China
- Aumake New Incubation Model & Bio Basic Launch
- Preliminary Final Report
- Full year sales rise 50% to $39m
- FY26 Business Streamlining
Later from Xenitra
- Trading Halt
- $1.5m Raised to Support Business Growth
- Aumake Enters High-Growth China OTC Medicine Market
- Quarterly Activities/Appendix 4C Cash Flow Report
- $10m Exclusive Dist Agreement with EZZ Life Sciences
Follow Xenitra into a list and get an email when it puts out news.
Follow Xenitra